SG49715A1 - Alkali metal 8,9-dehydroestrone sulfate esters - Google Patents

Alkali metal 8,9-dehydroestrone sulfate esters

Info

Publication number
SG49715A1
SG49715A1 SG1996004314A SG1996004314A SG49715A1 SG 49715 A1 SG49715 A1 SG 49715A1 SG 1996004314 A SG1996004314 A SG 1996004314A SG 1996004314 A SG1996004314 A SG 1996004314A SG 49715 A1 SG49715 A1 SG 49715A1
Authority
SG
Singapore
Prior art keywords
alkali metal
sulfate esters
dehydroestrone sulfate
dehydroestrone
esters
Prior art date
Application number
SG1996004314A
Other languages
English (en)
Inventor
Panolil Chirukan Raveendranath
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of SG49715A1 publication Critical patent/SG49715A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
SG1996004314A 1992-02-26 1993-02-19 Alkali metal 8,9-dehydroestrone sulfate esters SG49715A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/841,694 US5210081A (en) 1992-02-26 1992-02-26 Alkali metal 8,9-dehydroestrone sulfate esters

Publications (1)

Publication Number Publication Date
SG49715A1 true SG49715A1 (en) 1998-06-15

Family

ID=25285489

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004314A SG49715A1 (en) 1992-02-26 1993-02-19 Alkali metal 8,9-dehydroestrone sulfate esters

Country Status (22)

Country Link
US (3) US5210081A (fr)
EP (2) EP0864583B1 (fr)
JP (1) JP3715645B2 (fr)
KR (1) KR100256861B1 (fr)
AR (2) AR042262A2 (fr)
AT (2) ATE174342T1 (fr)
AU (2) AU677181B2 (fr)
CA (1) CA2089707A1 (fr)
DE (2) DE69322497T2 (fr)
DK (2) DK0864583T3 (fr)
ES (2) ES2274555T3 (fr)
FI (1) FI115915B (fr)
GR (1) GR3029620T3 (fr)
HK (2) HK1011369A1 (fr)
HU (2) HUT67553A (fr)
LV (1) LV12240B (fr)
MX (1) MX9300969A (fr)
PT (1) PT864583E (fr)
SG (1) SG49715A1 (fr)
TW (1) TW257677B (fr)
WO (1) WO1993017036A1 (fr)
ZA (1) ZA93746B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
DE19631542C1 (de) * 1996-07-25 1997-08-28 Schering Ag Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten II
DE19631543C1 (de) * 1996-07-25 1997-11-20 Schering Ag Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten I
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
AR014096A1 (es) * 1996-10-11 2001-02-07 Wyeth Corp 17 alfa,8,9-deshidroestradiol y 17 beta delta 8,9 deshidroestradiol, el uso de los mismos para la manufactura de un medicamento, una composicionfarmaceutica que los comprende y un procedimiento para su preparacion.
ZA979204B (en) * 1996-10-16 1999-04-14 American Home Prod Use of 8,9-dehydroestrone in treating vasomotor symptoms
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
US6432643B1 (en) 1999-10-22 2002-08-13 Duke University Method of determining Alzheimer's disease risk using apolipoprotein E4 genotype analysis in combination with decreased estrogen levels
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) * 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US8349819B2 (en) * 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (fr) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Procede d'administration d'oestrogenes et de progestatifs
JP5000509B2 (ja) * 2004-06-07 2012-08-15 ワイス・エルエルシー 糖被覆物及び被覆方法
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
WO2006084082A1 (fr) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
US20070003623A1 (en) * 2005-06-29 2007-01-04 Wyeth Formulations of conjugated estrogens and bazedoxifene
EP2289487A1 (fr) * 2005-12-27 2011-03-02 Teva Women's Health, Inc. Compositions d'estrogènes conjgués, applicateurs, kits et procédés pour les préparer et les utiliser
BRPI0718558A2 (pt) * 2006-11-07 2013-11-19 Wyeth Corp Forma de dosagem sólida, composição aquosa, método para preparar uma forma de dosagem sólida, e, produto
CN101631536A (zh) * 2007-01-12 2010-01-20 惠氏公司 片中片组合物
WO2008100769A2 (fr) * 2007-02-09 2008-08-21 Wyeth Procédé de sulfatation sélective de groupements hydroxyles aromatiques
US7902147B2 (en) * 2007-11-05 2011-03-08 Duke University Chronic lymphocytic leukemia prognosis and treatment
ES2436841T3 (es) 2009-10-27 2014-01-07 Wyeth Llc Formulaciones de bazedoxifeno con antioxidantes

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834712A (en) * 1953-05-27 1958-05-13 American Home Prod Urinary estrogen compositions and methods for preparing them
US3079410A (en) * 1960-04-02 1963-02-26 Hoechst Ag Process for stabilizing anionic and cationic ester salts of 21-hydroxy-20-ketosteroids in an aqueous solution
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
DE1200476B (de) * 1961-04-10 1965-09-09 Frosst & Co Charles E Stabilisierung von trockenen Zubereitungen synthetischer Alkalisalze von OEstronsulfat
US3551459A (en) * 1962-10-04 1970-12-29 Herchel Smith 13-methyl-8-isogonanes
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
NL6805153A (fr) * 1968-04-10 1969-10-14
US3644618A (en) * 1968-10-29 1972-02-22 Frosst & Co Charles E Stable composition of synthetic sodium estrone sulfate
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
GB1451109A (en) * 1973-08-17 1976-09-29 Rech Et Dapplications Scient S Derivatives of oestrone and their use in therapy
GB1528321A (en) * 1975-07-07 1978-10-11 Leo Ab Acylation process for the preparation of phenolic n,n-di-substituted carbamate esters
SE439586B (sv) * 1975-09-05 1985-06-24 Kanebo Ltd Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Also Published As

Publication number Publication date
DK0864583T3 (da) 2006-12-04
GR3029620T3 (en) 1999-06-30
DE69322497D1 (de) 1999-01-21
EP0628052B1 (fr) 1998-12-09
US5288717A (en) 1994-02-22
DE69334073T2 (de) 2007-02-01
AU711571B2 (en) 1999-10-14
ZA93746B (en) 1994-08-03
FI943903A0 (fi) 1994-08-25
LV12240A (lv) 1999-03-20
FI115915B (fi) 2005-08-15
FI943903A (fi) 1994-08-25
JP3715645B2 (ja) 2005-11-09
AU3726093A (en) 1993-09-13
AR042345A2 (es) 2005-06-15
DE69322497T2 (de) 1999-05-06
AU2007697A (en) 1997-07-03
KR950700318A (ko) 1995-01-16
ATE174342T1 (de) 1998-12-15
AR042262A2 (es) 2005-06-15
ATE342272T1 (de) 2006-11-15
PT864583E (pt) 2007-01-31
HU9402457D0 (en) 1994-10-28
HU211971A9 (en) 1996-01-29
LV12240B (en) 1999-06-20
EP0864583B1 (fr) 2006-10-11
EP0628052A1 (fr) 1994-12-14
WO1993017036A1 (fr) 1993-09-02
HUT67553A (en) 1995-04-28
TW257677B (fr) 1995-09-21
JPH07504197A (ja) 1995-05-11
ES2274555T3 (es) 2007-05-16
AU677181B2 (en) 1997-04-17
US6169082B1 (en) 2001-01-02
EP0864583A3 (fr) 2004-07-21
CA2089707A1 (fr) 1993-08-27
EP0864583A2 (fr) 1998-09-16
MX9300969A (es) 1993-09-01
ES2125975T3 (es) 1999-03-16
HK1020282A1 (en) 2000-04-07
DE69334073D1 (de) 2006-11-23
HK1011369A1 (en) 1999-07-09
DK0628052T3 (da) 1999-07-12
US5210081A (en) 1993-05-11
KR100256861B1 (ko) 2000-08-01

Similar Documents

Publication Publication Date Title
HK1020282A1 (en) Alkali metal 8,9-dehydroestrone sulfate esters
GB2290537B (en) Alkali metal dispersions
ZA9410209B (en) Metal wall framing
GB9310937D0 (en) Shaping metal
GB2276887B (en) Coated metal
ZA938469B (en) Metal accumulation
GB2319024B (en) Alkali metal dispersions
GB9326299D0 (en) Metal structures
GB9402610D0 (en) Metal casting
GB9221842D0 (en) Lance
EP0571732A3 (fr) Four pour la fusion de métaux.
GB2240986B (en) Metal complex compounds
AU121576S (en) Metal section
GB9227076D0 (en) Metal structures
PL54232Y1 (en) Metal shape
AU108932S (en) Metal section
AU108934S (en) Metal section
AU108933S (en) Metal section
AU108937S (en) Metal section
AU108938S (en) Metal section
AU108020S (en) Metal section
AU108936S (en) Metal section
AU108939S (en) Metal section
AU108935S (en) Metal section
GB9224031D0 (en) Metal coatings